Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan

Go back to Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan
Bristol-Myers Squibb (NYSE: BMY) Delayed: 63.64 -0.11 (0.17%)
Previous Close $63.75    52 Week High $77.12 
Open $64.15    52 Week Low $49.03 
Day High $64.20    P/E 41.32 
Day Low $63.27    EPS $1.54 
Volume 7,055,830       

Pfizer Inc. (NYSE: PFE) Delayed: 27.72 +0.07 (0.25%)
Previous Close $27.65    52 Week High $37.39 
Open $27.80    52 Week Low $28.25 
Day High $27.85    P/E 16.80 
Day Low $27.42    EPS $1.65 
Volume 25,551,822       

PORTOLA PHARMAC (NASDAQ: PTLA) Delayed: 18.03 --0 (-0%)
Previous Close $18.03    52 Week High $52.89 
Open $0.13    52 Week Low $15.68 
Day High $18.03    P/E 41.93 
Day Low $18.03    EPS $0.43 
Volume 15